Skip to main content

Advertisement

Log in

Occupational and environmental scleroderma. Systematic review and meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The etiology of systemic sclerosis (SSc) remains unknown; however, several occupational and environmental factors have been implicated. Our objective was to perform a meta-analysis of all studies published on SSc associated with occupational and environmental exposure. The review was undertaken by means of MEDLINE and SCOPUS from 1960 to 2014 and using the terms: “systemic,” “scleroderma,” or “systemic sclerosis/chemically induced” [MesH]. The Newcastle-Ottawa Scale was used for the qualifying assessment. The inverse variance-weighted method was performed. The meta-analysis of silica exposure included 15 case-control studies [overall OR 2.81 (95%CI 1.86–4.23; p < 0.001)] and 4 cohort studies [overall RR 17.52 (95%CI 5.98–51.37; p < 0.001)]; the meta-analysis of solvents exposure included 13 case-control studies (overall OR 2.00 [95%CI 1.32–3.02; p = 0.001); the meta-analysis of breast implants exposure included 4 case-control studies (overall OR 1.68 (95%CI 1.65–1.71; p < 0.001)) and 6 cohort studies (overall RR 2.13 (95%CI 0.86–5.27; p = 0.10)); the meta-analysis of epoxy resins exposure included 4 case-control studies (overall OR 2.97 (95%CI 2.31–3.83; p < 0.001)), the meta-analysis of pesticides exposure included 3 case-control studies (overall OR 1.02 (95%CI 0.78–1.32; p = 0.90)) and, finally, the meta-analysis of welding fumes exposure included 4 studies (overall OR 1.29 (95%CI 0.44–3.74; p = 0.64)). Not enough studies citing risks related to hair dyes have been published to perform an accurate meta-analysis. Silica and solvents were the two most likely substances related to the pathogenesis of SSc. While silica is involved in particular jobs, solvents are widespread and more people are at risk of having incidental contact with them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bramwell B (1914) Diffuse sclerodermia: its frequency; its occurrence in stone-masons; its treatment by fibrolysin-elevations of temperature due to fibrolysin injections. Edinburgh Med J 12:387–340

    Google Scholar 

  2. Erasmus LD (1957) Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 3:209–231

    CAS  PubMed  Google Scholar 

  3. McHugh NJ, Whyte J, Harvey G, Haustein UF (1994) Anti-topoisomerase I antibodies in silica associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum 37:1198–1205

    Article  CAS  PubMed  Google Scholar 

  4. McCormic ZD, Khuder SS, Aryal BK, Ames AL, Khuder SA (2010) Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health 83:763–769

    Article  CAS  PubMed  Google Scholar 

  5. Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W (1995) Scleroderma and occupational exposure. Scand J Work Environ Health 21:289–292

    Article  CAS  PubMed  Google Scholar 

  6. Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A (2004) A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77:10–16

    Article  PubMed  Google Scholar 

  7. Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ (1967) The association of progressive systemic sclerosis (scleroderma) with coal miner’s pneumoconiosis and other forms of silicosis. Ann Intern Med 66:323–334

    Article  CAS  PubMed  Google Scholar 

  8. Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis and progressive systemic sclerosis. BJ Ind Med 42:838–843

    CAS  Google Scholar 

  9. Ziegler V, Enderlein G, Mehlhorn J (1997) Retrospective epidemiological analysis of the relation between progressive systemic scleroderma and the exposure to quartz dust out of uranium ore mining in East Germany. Zentralbl Arbeitsmed 47:7–13

    CAS  Google Scholar 

  10. Brown LM, Gridley J, Olsen JH, Mellemkjaer L, Linet MS, Fraumeni JF Jr (1997) Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 39:633–638

    Article  CAS  PubMed  Google Scholar 

  11. Mehlhorn J, Enderlein G, Conrad K (1999) Analysis for the association between progressive systemic scleroderma exposure to quartz dust and silicosis in east German uranium mining. Zbl Arbeitsmed 49:134–147

    CAS  Google Scholar 

  12. Englert H, Small-Mcmahon J, Davis K et al (2000) Male systemic sclerosis and occupational silica exposure—a population-based study. Aust NZ J Med 30:215–220

    Article  CAS  Google Scholar 

  13. Burns CJ, Laing TJ, Gillespie BW et al (1996) The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 23:1904–1911

    CAS  PubMed  Google Scholar 

  14. Walsh SJ (1999) Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis. J Rheumatol 26:2179–2185

    CAS  PubMed  Google Scholar 

  15. Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lacey JV, Laing TJ, Gillespie BW (1997) Epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 24:1854–1855

    Google Scholar 

  17. Gold LS, Ward MH, Dosemeci M, De Roos AJ (2007) Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 56:3189–3201

    Article  CAS  PubMed  Google Scholar 

  18. Rosenman KD, Moore-Fuller M, Reilly MJ (1999) Connective tissue disease and silicosis. Am J Ind Med 35:375–381

    Article  CAS  PubMed  Google Scholar 

  19. Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322–1324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Makol A, Reilly MJ, Rosenman KD (2011) Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 54:255–262

    Article  PubMed  Google Scholar 

  21. Maitre A, Hours M, Bonneterre V et al (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31:2395–2401

    CAS  PubMed  Google Scholar 

  22. Diot E, Lesire V, Guilmot JL et al (2002) Systemic sclerosis and occupational risk factors: a case control study. Occup Environ Med 59:545–549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mora G. 2003 Esclerodermia inducida por sílice. Tesis Doctoral. Facultad de Medicina, Universidad de Buenos Aires, Argentina.

  24. Thompson AE, Pope JE (2002) Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 29:1867–1873

    PubMed  Google Scholar 

  25. Marie I, Gehanno JF, Bubenheim M et al (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156

    Article  CAS  PubMed  Google Scholar 

  26. Zachariae H, Bjerring P, Søndergaard KH, Halkier-Sørensen L (1997) Occupational systemic sclerosis in men. Ugeskr Laeger 159:2687–2689

    CAS  PubMed  Google Scholar 

  27. Freire M, Alonso M, Rivera A, Sousa A, Soto A, Gómez-Sousa JM, Baroja A, Vázquez-Triñanes C, Sopeña B (2015) Clinical peculiarities of patients with scleroderma exposed to silica: a systematic review of the literature. Semin Arthritis Rheum 45:294–300

    Article  CAS  PubMed  Google Scholar 

  28. Reinl W (1957) Scleroderma caused by trichloroethylene effects. Zentralbl Arbeitsmed 7:58–60

    CAS  PubMed  Google Scholar 

  29. Walder G (1965) Solvents and scleroderma. Lancet 28:436–437

    Article  Google Scholar 

  30. Aryal BK, Khuder SA, Schaub EA (2001) Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 40:271–274

    Article  CAS  PubMed  Google Scholar 

  31. Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Tolédano C, Fabre B et al (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a meta-analysis of case-control studies. J Rheumatol 34:97–103

    CAS  PubMed  Google Scholar 

  32. Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A (2012) Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 7:1–18

    Google Scholar 

  33. Garabrant DH, Lacey JV, Laing TJ et al (2003) Scleroderma and solvent exposure among women. Am J Epidemiol 157:493–500

    Article  PubMed  Google Scholar 

  34. Lacey JV, Garabrant DH, Gillespie BW (1997) Self-reported exposure to solvents in women with systemic sclerosis. Arthritis Rheum 40:1021

    Google Scholar 

  35. Laing TJ, Gillespie B, Burns C (1995) Risk factors for scleroderma among Michigan women. Arthritis Rheum 38(suppl 9):S341

    Google Scholar 

  36. Czirjak L, Bokk A, Csontos G, Lörincz G, Szegedi G (1989) Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol 69:533–536

    CAS  PubMed  Google Scholar 

  37. Goldman JA (1996) Connective tissue disease in people exposed to organic chemical solvents. Systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers. J Clin Rheumatol 2:185–190

    Article  CAS  PubMed  Google Scholar 

  38. Nietert PJ, Sutherland SE, Silver RM et al (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41:1111–1118

    Article  CAS  PubMed  Google Scholar 

  39. Czirják L, Kumánovics G (2002) Exposure to solvents in female patients with scleroderma. Clin Rheumatol 21:114–118

    Article  PubMed  Google Scholar 

  40. Arnaud J, De Gaudemaris R, Carpentier P (2002) Sclérodermie et facteurs professionneles de l’environnment : étude cas-témoins en population générale. Arch Mal Prof 63:144

    Google Scholar 

  41. Kütting B, Uter W, Drexler H (2006) Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma? J Occup Med Toxicol 1:1–6

    Article  Google Scholar 

  42. Garabrant DH, Dumas C (2000) Epidemiology of organic solvents and connective tissue disease. Arthritis Res 2:5–15

    Article  CAS  PubMed  Google Scholar 

  43. Sverdrup B (1984) Do workers in the manufacturing industry run an increased risk of getting scleroderma? Int J Dermatol 23:629

    Article  CAS  PubMed  Google Scholar 

  44. Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S (1994) Occupation, occupational exposure to chemicals and rheumatological disease. Scand J Rheumatol 23:305–310

    Article  CAS  PubMed  Google Scholar 

  45. Perkins LL, Clark BD, Klein PJ, Cook RR (1995) A meta-analysis of breast implants and connective tissue disease. Ann Plast Surg 35:561–570

    Article  CAS  PubMed  Google Scholar 

  46. Hochberg MC, Perlmutter DL (1996) The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): a meta-analysis. Curr Top Microbiol Immunol 210:411–417

    CAS  PubMed  Google Scholar 

  47. Wong O (1996) A critical assessment of the relationship between silicone breast implants and connective tissue diseases. Regul Toxicol Pharmacol 23:74–85

    Article  CAS  PubMed  Google Scholar 

  48. Whorton D, Wong O (1997) Scleroderma and silicone breast implants. West J Med 167:159–165

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analysis of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790

    Article  CAS  PubMed  Google Scholar 

  50. Gabriel SE, O’Fallon M, Kurland LT, Beard CM, Woods JE, Melton LJ 3rd (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 24:1697–1702

    Article  Google Scholar 

  51. Brinton L, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC (2004) Risk of connective tissue disorders among breast implant patients. Am J Epidemiol 160:619–627

    Article  PubMed  Google Scholar 

  52. McLaughlin JK, Fraumeni JF, Olsen J, Mellemkjaer L (1994) Breast implants, cancer and systemic sclerosis. J Natl Cancer Inst 86:424

    Article  Google Scholar 

  53. Kjoller K, Friis S, Mellemkjaer L et al (2001) Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med 161:973–979

    Article  CAS  PubMed  Google Scholar 

  54. Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH (1995) Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 48:571–582

    Article  CAS  PubMed  Google Scholar 

  55. Fryzek JP, Holmich L, Mclaughlin JK et al (2007) A nationwide study of connective tissue disease and other rheumatic conditions among Danish women with long-term cosmetic breast implantation. Ann Epidemiol 17:374–379

    Article  PubMed  Google Scholar 

  56. Englert HJ, Brooks P (1994) Scleroderma and augmentation mammoplasty- a causal relationship? Aust NZ J Med 24:74–79

    Article  CAS  Google Scholar 

  57. Hochberg MC, Perlmutter DL, Medsger T et al (1996) Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39:1125–1131

    Article  CAS  PubMed  Google Scholar 

  58. Wigley FM, Miller R, Hochberg MC (1992) Augmentation mammoplasty in patients with systemic sclerosis: data from the Baltimore scleroderma research center and Pittsburgh scleroderma data bank. Arthritis Rheum 35(Suppl 9):S46

    Google Scholar 

  59. Hennekens CH, Lee IM, Cook NR et al (1996) Self-reported breast implants and connective-tissue diseases in female health professionals. JAMA 275:616–621

    Article  CAS  PubMed  Google Scholar 

  60. Yamakage A, Ishikawa H, Saito Y, Hattori A (1980) Occupational scleroderma like disorder occurring in men engaged in the polymerization of epoxy resins. Dermatologica 161:33–44

    Article  CAS  PubMed  Google Scholar 

  61. Freni-Titulaer LWJ, Kelley DB, Grow AG, McKinley TW, Arnett FC, Hochberg MC (1989) Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol 130:404–409

    Article  CAS  PubMed  Google Scholar 

  62. Wilson RH, McCormick WE, Tatum CF, Creech JL (1967) Occupational acroosteolysis. Report of 31 cases. JAMA 201:577–581

    Article  CAS  PubMed  Google Scholar 

  63. Veltman G, Lange CE, Jühe S, Stein G, Bachner U (1975) Clinical manifestations and course of vinyl chloride disease. Ann N Y Acad Sci 246:6–17

    Article  CAS  PubMed  Google Scholar 

  64. Ward AM, Udnoon S, Watkins J, Walker AE, Darke CS (1976) Immunological mechanisms in the pathogenesis of vinyl chloride disease. Br Med J 1:936–938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Posada de la Paz M, Philen RM, Abaitua I (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23:231–247

    Article  CAS  PubMed  Google Scholar 

  66. Mayes MD (1999) Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 107:743–748

    Article  PubMed  PubMed Central  Google Scholar 

  67. Hess EV (2002) Environmental chemicals and autoimmune disease: cause and effect. Toxicology 181-2:65–70

    Article  Google Scholar 

  68. Magnant J, Diot E (2006) Sclérodermie systémique : épidémiologie et facteurs environnementaux. Presse Med 35:1894–1901

    Article  PubMed  Google Scholar 

  69. Haustein UF, Ziegler V (1985) Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 24:147–151

    Article  CAS  PubMed  Google Scholar 

  70. Fishman SJ, Russo GG (1991) The toxic pseudosclerodermas. Int J Dermatol 30:837–842

    Article  CAS  PubMed  Google Scholar 

  71. Cooper GS, Miller FW, Germolec DR (2002) Occupational exposures and autoimmune diseases. Int Immunopharmacol 2:303–313

    Article  CAS  PubMed  Google Scholar 

  72. Silman AJ, Hochberg MC (1996) Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am 4:737–747

    Article  Google Scholar 

  73. Steen VD (1999) Occupational scleroderma. Curr Opin Rheumatol 11:490–494

    Article  CAS  PubMed  Google Scholar 

  74. Hallé O, Schaeverbeke T, Bannwarth B, Dehais J (1997) Les facteurs d’environment et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Méd Interne 18:219–229

    Article  PubMed  Google Scholar 

  75. Granel B, Zemour F, Lehucher-Michel MP, Moulin P, Disdier P, Durand JM et al (2008) Évaluation de l’exposition toxique professionnelle de patients atteints de sclérodermie systémique. Revue de la lilttérature et résultat d’un auto-questionnaire. Rev Méd Interne 29:891–900

    Article  CAS  PubMed  Google Scholar 

  76. Straniero NR, Furst DE (1989) Environmentally-induced systemic sclerosis-like illness. Baillieres Clin Rheumatol 3:63–79

    Article  CAS  PubMed  Google Scholar 

  77. Nietert PJ, Silver RM (2000) Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12:520–526

    Article  CAS  PubMed  Google Scholar 

  78. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:259–271

    Article  PubMed  PubMed Central  Google Scholar 

  79. D’Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112-113:421–432

    Article  PubMed  Google Scholar 

  80. Dospinescu P, Jones GT, Basu N (2013) Environmental risk factors in systemic sclerosis. Curr Opin Rheumatol 25:179–183

    Article  PubMed  Google Scholar 

  81. Schaeverbeke T, Hallé O, Moride Y (1995) Systemic sclerosis and prolonged exposure to toxics. Arthritis Rheum 38(Suppl 9):S332

    Google Scholar 

  82. Wells G, Shea B, O’Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology /oxford.htm.

  83. Kahn HA, Sempos CT.1989. Statistical Q14 methods in epidemiology. Oxford University Press.

  84. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  PubMed Central  Google Scholar 

  85. Begg CB, Berlin JA (1989) Publication bias and dissemination of clinical research. J Natl Cancer Inst 81:107–115

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Special acknowledgment is given to Sandra Stroo from Dallas, Texas (USA), for the revision of the present study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manuel Rubio-Rivas.

Ethics declarations

Conflict of interest

There is neither financial support nor conflict of interest.

The authors declare no conflict of interest, no source of funding or sponsors or any relationship to organizations that could potentially influence the present work.

Financial support

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rubio-Rivas, M., Moreno, R. & Corbella, X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol 36, 569–582 (2017). https://doi.org/10.1007/s10067-016-3533-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3533-1

Keywords

Navigation